polidocanol (asclera) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Dodecyl Ethyleneglycol Monoether (lauryl ethoxylate) is a nonionic compound, that used as environmentally friendly non-Ionic surfactant with marked antibacterial activity. Dodecyl Ethyleneglycol Monoether is effective permeation enhancer, both for the passive process as well as for samples subjected to iontophoresis.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

aethoxysclerol | aethoxysklerol | aethoxy-sklerol | aetoxisclerol | alpha-dodecyl-omega-hydroxypoly(oxy-1,2ethanediyl) | asclera | atossisclerol | atoxysclerol | ethoxysclerol | hydroxypolyethoxydodecane | laureth | laureth-4 | laureth-7 | laureth 9 | laureth-9 | lauromacrogol | lauromacrogol 400 | lubrol 12a9 | lubrol-px | macrogol 9 lauryl ether | nonaethylene glycol monododecyl ether | nonaethyleneglycol monododecyl ether | nonaethylene glycol monolauryl ether | peg-9 lauryl ether | polidocanol | polydocanol | polyethylene glycol 450 lauryl ether | polyethylene glycol monododecyl ether | polyoxyethylene-4-dodecyl ether | polyoxyethylene 9-lauryl ether | polyoxyethylenedodecyl ether | polyoxyethylene lauryl ether | polyoxyl 9 lauryl ether | tetraethyleneglycol lauryl ether | thesit | varithena

Organizations (38)

Research & Development (37)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (18)

Approved Indications (4)


 

Esophageal and Gastric Varices

Telangiectasis

Varicose Veins (approved 2012)

Venous Insufficiency (approved 2012)

Experimental Indications - Clinical Trial Phases 1-4 (17)


 

Achilles Tendon (Phase 4)

Apnea (Phase 1/Phase 2)

Body Fat Distribution (Phase 2)

Coronary Artery Disease (Phase 4)

Elbow (Phase 2)

Ganglion Cysts (Phase 4)

Gastroesophageal Reflux (Phase 4)

Hemorrhoids (Phase 4)

Leg Ulcer (Phase 4)

Melanoma (Phase 2)

Saphenous Vein (Phase 3)

Snoring (Phase 1/Phase 2)

Telangiectasis (Phase 4)

Tendinopathy (Phase 2)

Varicose Ulcer (Phase 4)

Varicose Veins (Phase 4)

Venous Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 31
  • # of Trial Organizations: 37

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue